APA (7th ed.) Citation

A, R., CM, D., G, F., A, C., ML, F., P, G., . . . T, B. (2010). A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms. British journal of haematology, 150(4), 446. https://doi.org/10.1111/j.1365-2141.2010.08266.x

Chicago Style (17th ed.) Citation

A, Rambaldi, et al. "A Pilot Study of the Histone-Deacetylase Inhibitor Givinostat in Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms." British Journal of Haematology 150, no. 4 (2010): 446. https://doi.org/10.1111/j.1365-2141.2010.08266.x.

MLA (9th ed.) Citation

A, Rambaldi, et al. "A Pilot Study of the Histone-Deacetylase Inhibitor Givinostat in Patients with JAK2V617F Positive Chronic Myeloproliferative Neoplasms." British Journal of Haematology, vol. 150, no. 4, 2010, p. 446, https://doi.org/10.1111/j.1365-2141.2010.08266.x.